CerebroSync
Science behind this product
-
Deanol for Tardive Dyskinesia
SourceTen hospitalized chronic psychotic patients with symptoms of tardive dyskinesia were given deanol and a placebo. Improvement occurred in all patients during the first treatment phase.
-
Bacopa Monnieri against Alzheimer's Disease
SourceThe overall studies have concluded that Bacopa monnieri can be used as a lead formulation for the treatment of Alzheimer's disease and other neurological disorders.
-
The association between magnesium intake and cardiovascular health
SourceThis study suggests that lower dietary magnesium intake was associated with higher BP and stroke risk, which may have implications for primary prevention.
-
DHA for Brain Functions
SourceDHA has a positive effect on diseases such as hypertension, arthritis, atherosclerosis, depression, adult-onset diabetes mellitus, myocardial infarction, thrombosis, and some cancers.
-
Tyrosine for Behavior and Cognition
SourceThe buffering effects of tyrosine on cognition may be explained by tyrosine's ability to neutralize depleted brain catecholamine levels. There is evidence that tyrosine may benefit healthy individuals exposed to demanding situational conditions.